Cargando…
Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
This cross-sectional study uses direct pharmaceutical claims data from a commercial claims database to assess the use of 6 types of immunosuppressive drugs among commercially insured US adults in 2018 and 2019.
Autores principales: | Wallace, Beth I., Kenney, Brooke, Malani, Preeti N., Clauw, Daniel J., Nallamothu, Brahmajee K., Waljee, Akbar K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138687/ https://www.ncbi.nlm.nih.gov/pubmed/34014329 http://dx.doi.org/10.1001/jamanetworkopen.2021.4920 |
Ejemplares similares
-
Prevalence and Prescribers of Preoperative Opioid Prescriptions in the US, 2008-2019
por: Howard, Ryan, et al.
Publicado: (2022) -
Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease
por: Konerman, Monica A, et al.
Publicado: (2019) -
Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022) -
Predicting 30-day hospital readmissions using artificial neural networks with medical code embedding
por: Liu, Wenshuo, et al.
Publicado: (2020) -
Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis
por: Stidham, Ryan W., et al.
Publicado: (2019)